1. Home
  2. LPA vs BNR Comparison

LPA vs BNR Comparison

Compare LPA & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LPA

Logistic Properties of the Americas

HOLD

Current Price

$3.82

Market Cap

93.9M

Sector

N/A

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$8.27

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPA
BNR
Founded
2013
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.9M
76.5M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
LPA
BNR
Price
$3.82
$8.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
228.4K
25.3K
Earning Date
05-13-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
$11.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.04
$3.11
52 Week High
$7.51
$41.72

Technical Indicators

Market Signals
Indicator
LPA
BNR
Relative Strength Index (RSI) 64.78 37.97
Support Level $2.53 $8.04
Resistance Level $3.86 $9.90
Average True Range (ATR) 0.33 0.83
MACD 0.11 0.31
Stochastic Oscillator 70.95 46.26

Price Performance

Historical Comparison
LPA
BNR

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has four operating segments, based on geographic regions, consisting of Colombia, Peru, Mexico and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: